display
Frankfurt / Hamburg (dpa) - The Frankfurt virologist Sandra Ciesek is skeptical that the budesonide asthma spray will be decisive in the fight against Covid-19.
"I would not call it a" game changer ", said the director of the Institute for Medical Virology at the University Hospital Frankfurt on Tuesday evening in the NDR podcast" The Coronavirus Update ".
SPD health expert Karl Lauterbach had called the Oxford University study published in "The Lancet" a possible "game changer".
"The results make clinical sense because the anti-inflammatory effect in the lungs can prevent the deterioration of lung function," wrote the doctor on Twitter.
There are also hardly any side effects.
The study had "some weaknesses", countered Ciesek: Few patients, no control group - but above all, the oxygen demand of the patients did not change after administration of the spray.
"Still, of course, it gives hope," said Ciesek.
It is possible that “there may be subgroups who benefit from it”.
display
Under no circumstances should people get budesonide on their own now.
"Above all, you shouldn't take it prophylactically before you become infected, it wouldn't do anything and would even be counterproductive."
Ciesek would not place too much hope in UV rays and vitamin D. Vitamin D3 for the treatment of Covid-19 is no longer recommended in the guideline in German clinics.
UV light makes pathogens harmless - but only if they are free in the room, not in human cells.
“It is certainly not wrong for someone to sit on the balcony in the sun.
I just wouldn't expect much from it, ”says Ciesek.
© dpa-infocom, dpa: 210420-99-283197 / 2